THE IBOGA STORY
A Plant Medicine Challenging How We Understand Healing
For centuries, a West African shrub held secrets that Western medicine is only beginning to understand. Ibogaine—extracted from this sacred plant—is rewriting what's possible in treating addiction, trauma, and neurological disease.
WHAT IS IBOGAINE?
Ibogaine comes from Tabernanthe iboga, a shrub growing in the rainforests of Gabon and surrounding Central African nations. The Bwiti people have used iboga’s root bark in spiritual ceremonies for over a thousand years—a medicine facilitating ancestor communication, spiritual awakening, and profound psychological insight.
Western researchers stumbled upon ibogaine’s addiction-interrupting properties in the 1960s. What began as underground experimentation has evolved into clinical practice, with specialized medical centers now using ibogaine to address conditions that conventional treatment fails to reach.
Neuroplasticity & Healing
SOURCE: ROOT HEALING
Why Ibogaine Matters
Modern medicine excels at managing symptoms. Ibogaine addresses root causes—creating neurological shifts that enable genuine healing rather than indefinite management. This isn’t incremental improvement. It’s a fundamentally different approach.
Addiction Treatment
Traditional approaches manage dependency with maintenance drugs like methadone or Suboxone—trading one opioid for another. Ibogaine eliminates acute withdrawal within 24-36 hours and interrupts cravings at the neurological level, offering freedom rather than substitution.
Mental Health
Antidepressants and anti-anxiety medications modulate brain chemistry temporarily, requiring continuous use to maintain effects. Ibogaine appears to reset neurotransmitter systems entirely, creating lasting changes that persist long after the medicine clears your body.
Trauma Processing
Traditional trauma therapy processes memories cognitively through talk and exposure techniques. Ibogaine accesses deeply buried material that conscious recall cannot reach—allowing patients to process trauma that years of conventional therapy never touched.
Neurological Recovery
Where neurological disease is typically considered irreversible and treatment focuses solely on symptom management, ibogaine stimulates repair mechanisms we're only beginning to understand—offering hope for conditions modern medicine calls permanent.
OUR PHILOSOPHY
How Ibogaine Works
Scientists haven’t fully mapped ibogaine’s mechanisms—it’s pharmacologically complex, affecting multiple brain systems simultaneously. But clinical evidence and emerging research reveal several key actions:
Neurotransmitter Reset
Ibogaine affects serotonin, dopamine, glutamate, and opioid receptor systems at once—a multi-system recalibration that no other substance achieves. This creates the neurological space for new patterns to form.
Neuroplasticity Enhancement
Brain imaging shows ibogaine promotes growth of new neural pathways and repairs damaged connections. It’s not just symptom suppression—it’s structural brain change.
GDNF & BDNF Production
Ibogaine triggers release of glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF)—proteins that protect neurons, promote growth, and support recovery from neurological damage. This is particularly significant for Parkinson’s and TBI patients.
Pain Circuit Interruption
Through NMDA receptor antagonism, ibogaine disrupts chronic pain signaling—offering relief from neuropathic pain that opioids can’t touch without addiction risk.
Memory Processing
Ibogaine creates a unique psychological state—often described as “waking dream”—where deeply buried memories, traumas, and patterns surface for processing. Patients report accessing material that years of therapy never reached.
THE EXPERIENCE ITSELF
Understanding the Experience
Ibogaine is not recreational. It's not euphoric. It's work. The experience typically lasts 24-36 hours and demands complete surrender. Most patients lie still with eyes closed, navigating an internal landscape of memories, insights, and sensory experiences that defy easy description.
The Physical Journey
Temporary loss of coordination, nausea, visual distortions, and reduced heart rate. Uncomfortable but manageable under continuous medical supervision. Your body is working—this isn’t passive treatment.
The Psychological Journey
Profound introspection. Life review. Pattern recognition. Emotional release buried for years or decades. Sometimes difficult, occasionally transcendent, always significant. This is where healing happens.
What Comes After
A quieter mind. Reduced impulsivity. Clarity that wasn’t there before. The neurological reset creates space—what you do with that space determines whether change lasts. Ibogaine opens the door. Walking through it is your choice.
WHAT IBOGAINE CAN HEAL
Conditions Modern
Medicine Struggles to Treat
For conditions that resist conventional treatment—addiction, trauma, neurological disease, chronic pain—ibogaine offers breakthrough where other approaches fail.
Addiction & Substance
Dependency
Eliminates opioid withdrawal in 24-36 hours, reduces alcohol cravings 70-80%, interrupts stimulant dependency when methadone, Suboxone, and rehab fail.
Treatment-Resistant Mental
Health & Trauma
PTSD symptoms reduced 60-88%, depression unresponsive to medications, anxiety rooted in unprocessed trauma, grief that therapy couldn’t touch.
Neurological Conditions
& Chronic Pain
Parkinson’s tremor reduction, MS symptom improvement, TBI recovery, post-concussion syndrome, neuropathic pain, fibromyalgia, CTE management.
Safety: The Non-Negotiable
Medical Safety Protocols
Ibogaine affects cardiac electrical activity—specifically QT interval prolongation that can trigger dangerous arrhythmias. Without proper protocols, this creates serious risk. With them, ibogaine is extraordinarily safe. Here's how we ensure your safety:
Comprehensive cardiac screening before treatment
Complete EKG, echocardiogram when indicated, and thorough cardiovascular history review to identify any baseline risks or contraindications before you ever receive ibogaine.
Continuous EKG monitoring throughout the experience
Real-time cardiac telemetry tracking your heart rhythm every second of treatment—not periodic checks, but constant surveillance with automated alarms for any concerning changes.
Electrolyte optimization (magnesium, potassium, calcium)
IV supplementation 24-48 hours before treatment to optimize levels that protect against QT prolongation, with repeated testing to confirm your body is prepared for safe ibogaine administration.
Experienced physicians and ICU-trained nurses present
Not on-call—physically present throughout your entire treatment. Our medical team has supervised thousands of ibogaine sessions and knows how to recognize and respond to any complication within seconds.
Emergency equipment and response protocols
Defibrillators, emergency medications, airway management, IV access, and rehearsed protocols for every possible cardiac event. We're prepared for emergencies we hope never occur—but if they do, response time is measured in seconds, not minutes.
THE LEGAL LANDSCAPE
Ibogaine is Schedule I in the United States—federally illegal despite clinical evidence of therapeutic value. We operate legally where ibogaine is unscheduled. Canada allows personal importation, New Zealand permits restricted use, Europe mostly controls it. This policy failure forces patients abroad for life-saving medicine while blocking critical research.
WHAT SETS US APART
Ibogaine's story begins with the Bwiti people of Gabon, who have used iboga sacredly for over a millennium. We respect their tradition while applying ibogaine medically. We source sustainably, support fair compensation for source communities, acknowledge Bwiti cultural ownership, and use pharmaceutical-grade ibogaine—not sacred ceremonial preparations. The medicine crossed cultures. The ceremony remains Bwiti.
THE PATH FORWARD
The Future of Ibogaine
Research is finally catching up to clinical reality. After decades of clinical use, ibogaine is gaining institutional recognition. But while policy evolves slowly, people can't wait for bureaucracy to catch up with science.
Academic & Clinical Progress
Universities are studying ibogaine for TBI, PTSD, and addiction. The FDA granted Breakthrough Therapy designation for opioid use disorder. Veterans organizations are pushing for legalization. Peer-reviewed evidence is mounting.
Our Role Until Then
Until ibogaine becomes legally accessible in the United States, we'll continue providing medical-grade treatment where it's legal—building clinical evidence, refining safety protocols, and documenting outcomes that will force policy reform.
The Question: When, Not If
This medicine works. The science confirms what clinicians have known for decades. The question isn't whether ibogaine should be available—it's how many more will suffer needlessly before drug policy catches up with reality.
FAQ
Questions We Often Hear
What exactly is ibogaine?
Ibogaine is a naturally occurring psychoactive alkaloid extracted from the root bark of Tabernanthe iboga, a shrub native to Central Africa. Chemically, it’s an indole alkaloid that affects multiple neurotransmitter systems simultaneously—dopamine, serotonin, glutamate, and opioid receptors. This multi-system interaction is what makes it uniquely effective for addiction, trauma, and neurological conditions.
How is ibogaine different from other psychedelics?
Unlike psilocybin, LSD, or ayahuasca, ibogaine isn’t primarily about mystical experience or ego dissolution. It’s longer-lasting (24-36 hours vs. 4-8 hours), physically demanding, and specifically interrupts addiction pathways. While other psychedelics enhance neuroplasticity, ibogaine uniquely eliminates opioid withdrawal, resets dopamine systems, and stimulates GDNF production for neurological repair. It’s a medicine, not a spiritual journey—though profound insights often occur.
Why isn't ibogaine legal in the United States?
Ibogaine was classified as Schedule I in 1970 under the Controlled Substances Act—grouped with heroin and LSD as having “no accepted medical use.” This happened before any clinical research could establish its therapeutic potential. Despite decades of evidence from international clinics, rescheduling requires extensive FDA trials, which are only now beginning. Politics and drug policy inertia keep it illegal, not lack of efficacy.
Is ibogaine FDA-approved for anything?
No. Ibogaine has not been approved by the FDA for any medical use. However, the FDA did grant Breakthrough Therapy designation in 2023 to research studying ibogaine for opioid use disorder—acknowledging its potential. Until FDA approval occurs, Americans must travel to countries where ibogaine is legal to access treatment.
Where does ibogaine come from?
The ibogaine used in clinical settings is extracted from Tabernanthe iboga root bark harvested primarily in Gabon, Cameroon, and the Congo Basin. Ethical providers source from sustainable harvesting operations that compensate local communities fairly and don’t deplete wild populations. Some ibogaine is also synthetically produced in laboratories, ensuring consistent purity without environmental impact.
How does ibogaine eliminate opioid withdrawal?
The exact mechanism isn’t fully understood, but ibogaine appears to reset opioid receptor sensitivity and restore dopamine system function that chronic opioid use has disrupted. It also blocks NMDA receptors involved in withdrawal symptoms. Patients who would normally experience severe withdrawal (sweating, pain, nausea, anxiety) after stopping opioids report minimal to no symptoms after ibogaine treatment.
Can ibogaine cure addiction permanently?
No medicine “cures” addiction permanently—recovery requires ongoing effort. What ibogaine does is eliminate the physical dependency and neurological cravings that make sobriety nearly impossible. It creates a window of clarity—typically several months—where patients aren’t fighting constant urges. What they do during that window (therapy, lifestyle changes, support systems) determines long-term success. About 70-80% of patients remain abstinent at 6-month follow-up.
Does ibogaine work for alcoholism?
Yes. Clinical evidence shows ibogaine significantly reduces alcohol cravings and consumption. It’s particularly effective for people who’ve failed traditional rehab or struggle with severe dependency. However, alcohol withdrawal can be medically dangerous and requires careful management. Patients must be medically stable and properly tapered before ibogaine treatment.
What conditions does ibogaine NOT treat?
Ibogaine doesn’t treat active psychosis, schizophrenia, or severe bipolar disorder—it can worsen these conditions. It’s not appropriate for certain cardiac conditions, uncontrolled seizure disorders, or during pregnancy. It won’t treat conditions unrelated to brain chemistry or addiction (cancer, autoimmune diseases, most chronic illnesses). It’s powerful medicine with specific applications, not a cure-all.
How long have people been using ibogaine medically?
The Bwiti people have used iboga ceremonially for over 1,000 years. Western medical use began in the 1960s when researcher Howard Lotsof discovered its anti-addictive properties. Clinical ibogaine treatment centers emerged in the 1980s-90s, primarily, the Netherlands, and Canada. We now have over 50 years of documented medical use and thousands of case studies demonstrating efficacy.
Is treatment safe?
Treatment safety depends entirely on the clinic, not the country. Our facility operates at hospital standards with ICU-level equipment and protocols. The risk comes from unregulated clinics without proper medical oversight. Research providers carefully—credentials, equipment, safety records, and medical protocols matter more than location.
How much research exists on ibogaine?
Hundreds of peer-reviewed studies, case reports, and clinical observations spanning 50+ years. Research includes opioid addiction outcomes, PTSD treatment efficacy, Parkinson’s symptom improvement, TBI recovery, and safety protocols. However, large-scale randomized controlled trials are limited due to legal restrictions. Most evidence comes from observational studies, clinic outcome data, and international research outside the U.S.
Can I do ibogaine at home?
Absolutely not. Ibogaine requires continuous cardiac monitoring, physician oversight, emergency equipment, and medical expertise. Attempting ibogaine without proper medical supervision has caused deaths—primarily from undiagnosed cardiac issues or drug interactions. Underground ibogaine use is extremely dangerous. If you’re serious about ibogaine treatment, go to a legitimate medical facility.
What happens after ibogaine treatment?
The immediate neurological reset lasts days to weeks. Physical withdrawal symptoms stay eliminated. Psychological clarity can persist months. But ibogaine isn’t a magic cure—it’s a powerful reset that creates opportunity. Integration work (therapy, lifestyle changes, support systems) determines whether benefits last. Many patients return for “booster” treatments every 6-12 months to maintain neurological benefits.
Does insurance cover ibogaine treatment?
No. Because ibogaine isn’t FDA-approved and treatment occurs outside the U.S., American insurance doesn’t cover it. Some patients successfully appeal for reimbursement by documenting failed conventional treatments and medical necessity. Health Savings Accounts (HSAs) can sometimes be used. International insurance policies vary. Most patients pay out-of-pocket.
